Enhancement of the in vitro activity of amphotericin B against the biofilms of non-albicans Candida spp. by rifampicin and doxycycline

References

1. Arroyo J., Medoff G., Kobayashi G. S. 1977; Therapy of murine aspergillosis with amphotericin B in combination with rifampin or 5-fluorocytosine. Antimicrob Agents Chemother 11:21–25 [CrossRef]
   [Google Scholar]
2. Baillie G. S., Douglas L. G. 1998; Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob Agents Chemother 42:1900–1905
   [Google Scholar]
3. Battaner E., Vasquez D. 1971; Inhibitors of protein synthesis by ribosomes of the 8-S type. Biochim Biophys Acta 254:316–330 [CrossRef]
   [Google Scholar]
4. Chandra J., Mukherjee P. K., Leidich S. D., Faddoul F. F., Hoyer L. L., Douglas L. J., Ghannoum M. A. 2001; Antifungal resistance of candidal biofilms formed on denture acrylic in vitro . J Dent Res 80:903–908 [CrossRef]
   [Google Scholar]
5. Christenson J. C., Itamar Shalit T., David T., Welch F., Guruswamy A., Marks M. I. 1987; Synergistic action of amphotericin B and rifampin against Rhizopus species. Antimicrob Agents Chemother 31:1775–1778 [CrossRef]
   [Google Scholar]
6. Clinical and Laboratory Standards Institute 2002 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts ; approved standard, 2nd edn, document M27–2A. Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
7. Costerton J. W., Stewart P., Greenberg E. 1999; Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322 [CrossRef]
   [Google Scholar]
8. Dorocka-Bobkowska B., Konopka K., Düzgünes N. 2003; Influence of antifungal polyenes on the adhesion of Candida albicans and Candida glabrata to human epithelial cells in vitro . Arch Oral Biol 48:805–814 [CrossRef]
   [Google Scholar]
9. Douglas L. J. 2003; Candida biofilms and their role in infection. Trends Microbiol 11:30–36 [CrossRef]
   [Google Scholar]
10. Edwards J. E., Morrison J., Henderson D. K., Montgomerie J. Z. 1980; Combined effect of amphotericin B and rifampin on Candida species. Antimicrob Agents Chemother 17:484–487 [CrossRef]
    [Google Scholar]
11. El-Azizi M. A., Starks S., Khardori N. 2004; Interactions of Candida albicans and other Candida spp. and bacteria in the biofilms. J Appl Microbiol 96:1067–1073 [CrossRef]
    [Google Scholar]
12. El-Azizi M., Rao S., Kanchanapoom T., Khardori N. 2005; In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Ann Clin Microbiol Antimicrob 4:2 [CrossRef]
    [Google Scholar]
13. Ellepola A. N., Samaranayake L. P. 1998; Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents. Arch Oral Biol 43:999–1007 [CrossRef]
    [Google Scholar]
14. Hughes C. E., Harris L. C., Peterson L. R., Gerding D. N. 1984; Enhancement of the in vitro activity of amphotericin B against Aspergillus spp. by tetracycline analogs. Antimicrob Agents Chemother 26:837–840 [CrossRef]
    [Google Scholar]
15. Huppert M., Sun S. H., Vukovich K. R. 1974; Combined amphotericin B-tetracycline therapy for experimental coccidioidomycosis. Antimicrob Agents Chemother 5:473–478 [CrossRef]
    [Google Scholar]
16. Kinsky S. C. 1970; Antibiotic interactions with model membranes. Annu Rev Pharmacol 10:119–142 [CrossRef]
    [Google Scholar]
17. Krcmery V., Barnes A. J. 2002; Non- albicans Candida sp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50:243–260 [CrossRef]
    [Google Scholar]
18. Kuhn D. M., Chandra J., Mukherjee P. K., Ghannoum M. A. 2002; Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70:878–888 [CrossRef]
    [Google Scholar]
19. Kumamoto C. A. 2002; Candida biofilms. Curr Opin Microbiol 5:608–611 [CrossRef]
    [Google Scholar]
20. Lew M. A., Beckett K. M., Levin M. S. 1977; Antifungal activity of four tetracycline analogues in vitro : potentiation by amphotericin B. J Infect Dis 136:263–270 [CrossRef]
    [Google Scholar]
21. Lewis R. E., Kontoyiannis D. P., Darouiche R. O., Raad I. I., Prince R. A. 2002; Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother 46:3499–3505 [CrossRef]
    [Google Scholar]
22. Lou P., Kazdan J., Bannatyne R. M., Cheung R. 1977; Successful treatment of Candida albicans endophthalmitis with a synergistic combination of amphotericin B and rifampin. Am J Ophthalmol 83:12–15 [CrossRef]
    [Google Scholar]
23. Mah T. F., O’Toole G. A. 2001; Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9:34–39 [CrossRef]
    [Google Scholar]
24. Marrie T. J., Costerton J. W. 1984; Scanning and transmission electron microscopy of in situ bacterial colonization of intraatrial catheter. J Clin Microbiol 19:687–693
    [Google Scholar]
25. Medoff G., Kobayashi G. S., Kwan C. N., Schlessinger D., Venkov P. 1972; Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B. Proc Natl Acad Sci U S A 69:196–199 [CrossRef]
    [Google Scholar]
26. Pfaller M. A., Jones R. N., Doern G. V., Sader H. S., Messer S. A., Houston A., Coffman S., Hollis R. J., the SENTRY Participant Group Jr. 2000; Bloodstream infections due to Candida Species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 44:747–751 [CrossRef]
    [Google Scholar]
27. Ramage G., Vande Walle K., Wickes B. L., Lopez-Ribot J. L. 2001; Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45:2475–2479 [CrossRef]
    [Google Scholar]
28. Samaranayake Y. H., Ye J., Yay J. Y., Cheung B. P. 2005; In vitro method to study antifungal perfusion in Candida biofilms. J Clin Microbiol 43:818–825 [CrossRef]
    [Google Scholar]